2Yancik R, Ries L A. Aging and cancer in America. Demographic and epidemiologic perspectives[J].Hematol Oncol Clin North Am,2000,14(1) :17-23.
3Desch C E, Benson A B, Somerield M R,et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical On cology practice guideline[J].J Clin Oncol, 2005, 23(33) : 8512- 8519.
4Moertel C G, Fleming T R, Macdonald J S, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma[J]. N EnglJ Med, 1990, 322(6):352-358.
5Balducci L, Extermann M. Management of cancer in the older per son: a practical approach[J]. Oncologist, 2000,5(3):224-237.
6O'Connell J B, Maggard M A, Ko C Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging[J]. J Natl Cancer Inst, 2004, 96(19) :1420-1425.
7Haller D G, Catalano P J, Macdonald J S, et al. Fluorouracil, Leucovorin and Levamisole adjuvant therapy for colon cancer: five year final report of INT 0089[J]. Prog Proc Am Soc Clin Oncol, 1998, 17:256.
8Andre T, Boni C, Mounedji-Boudiafl, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J]. N EnglJ Med, 2004, 351(22):2340-2351.
9Sargent D J, Goldberg R M, Jaeobson S D, et al. A pooled analysis of adjuvant chemotherapy for reseeted colon cancer in elderly patients[J]. N EnglJ Med, 2001, 345(15):1091-1097.
10Zuckerman I H, Davidoff A J, Onulwagha E, et al. Effect of age on survival benefit of adjuvant chemotherapy in eldly stage Ⅲ colon cancer patients;a population-based analysis [J].J Clin Oncol, 2008,26(20 Suppl) :4014.
